<DOC>
	<DOCNO>NCT02572089</DOCNO>
	<brief_summary>To determine pharmacokinetics 4 intranasal dose naloxone compare 0.4 mg dose naloxone administrate intramuscular identify appropriate intranasal dose could achieve systemic exposure comparable approve parenteral dose . To also determine pharmacokinetics two different concentration intranasal naloxone finally , determine safety intranasal naloxone respect nasal irritation .</brief_summary>
	<brief_title>Pharmacokinetic Evaluation Intranasal Intramuscular Naloxone Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Drug Overdose</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Be able provide write consent Must BMI range 18 30kg/m2 , inclusive Must adequate venous access Must clinically significant concurrent medical condition determine medical history , physical examination , vital sign , 12lead electrocardiogram . Must agree use reliable doublebarrier method birth control start screen one week complete study . Oral contraceptive prohibit . Must agree ingest alcohol , drink contain xanthine great 500 mg/day ( e.g. , Coca Cola , coffee , tea , etc . ) , grapefruit/grapefruit juice participate strenuous exercise 72 hour prior admission last blood draw study . Please contact clinical site directly information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>